Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience

Complex care in the hemato-oncological ICU sometimes requires the use of CRRT. As the hemato-oncological patients have some specifications we retrospectively followed up the results of our effort in patients with acute renal failure due to veno-occlusive disease (VOD) after allogeneic hematopoietic stem cell transplantation. VOD is one of the most severe early complications in this type of patients and its mortality is high.